← Leaderboards
Mika Shimoji
Otomagnetics, Inc.
$2,525,578
Attributed
$2,525,578
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2016–18$2M$1.5M$1M$500K$0
'16
'17
'18
Funding mix
By agency
NIH$2,525,578 · 2
By mechanism
N43$2,299,786 · 1
R43$225,792 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Animals”
- David Heimbrook · Leidos Biomedical Research, Inc.$534,904,829
- Richard Webby · St. Jude Children'S Research Hospital$259,408,394
- Eric S Lander · Whitehead Institute For Biomedical Res$209,574,154
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Richard K. Wilson · Washington University$130,501,539
- Mark S Klempner · Tufts Medical Center$129,182,794
Research focus
AnimalsMiddle EarDrug Delivery SystemsDoseTechnologyDevicesSteroidsTopical ApplicationChildhoodChildHearingMagnetismControl GroupsLeadAnatomyLearningHearing ImpairmentLabelAdverse EffectsChemotherapy-Oncologic ProcedureChemotherapyCognitive DevelopmentCarboplatinCisplatin
Grant awards (3)
Drug Delivery System to Save Hearing During Pediatric Chemotherapy Regimens. POP 09/19/17 - 06/18/18.$1,999,787
N43 · FY2018 · CA · contact PI
Drug Delivery System to Save Hearing During Pediatric Chemotherapy Regimens. POP 09/19/17 - 06/18/18.$299,999
N43 · FY2017 · CA · contact PI
Topical Middle Ear Drug Delivery without Tympanic Membrane Puncture$225,792
R43 · FY2016 · AI · contact PI